维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Lasseter KC"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Omapatrilat versus lisino- pril:efficacy and neurehorrnonal profile in salt-sensitive hypertensive patients显示文摘	Campese VM Lasseter KC Ferrario CM	2001	Hypertension2001，38，6：	1
2	Effect of sitagliptin,a dipeptidyl peptidase-4 inhibitor,on blood pressure in nondiabetic patients with mild to moderate hypertension显示文摘	Mistry GC Maes AL Lasseter KC	2008	J Clin Pharmcol2008，48，5：	1
3	Effect of sitagliptin, a dipeptidyl peptidase -4 inhibitor, on blood pressure in nondiabetlc patients with mild to moderate hypertension 显示文摘	Mistry GC Maes AL Lasseter KC	2008	J Clin Pharmacol2008，48，：	1
4	The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function 显示文摘	Eveson G Lassete KC Anderson KE	2000	Br j Clin Pharmacol2000，，：	1
5	The pharrnacokinetics of ziprasidone in subjects with normal and impaired hepatic func- tion 显示文摘	Eversong Lasseter KC Anderson KE	1997	Eur Neuropsychopharmacol1997，7，2：	1
6	Profile of etodolal:Pharmacokinetic evaluation in special populations 显示文摘	Brater DC Lasseter KC	1989	Clin Rheumatol1989，8，1：	1
7	Tolerability of fosa-prepitant and bioequivalency to aprepitant in healthy subjects显示文摘	LASSETER KC GAMBALE J JIN B	2007	y Clin Pharm’ 20072007，，：	1
8	Aclidinium bromide, a long-acting antimuscarinic, does not affect QT inter- val in healthy subjects 显示文摘	LASSETER KC AUBETS J CHUECOS F	2011	J Clin Pharmacol2011，51，6：	1
9	Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cericastatin or pravastatin显示文摘	Mazzu AL Lasseter KC Shamblen EC	2000	Clin Pharmacol Ther2000，68，4：	1
10	Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin显示文摘	Mazzu AL Lasseter KC Shamblen EC	2000	Clin Pharmacol Ther2000，68，4：	1
11	The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function显示文摘	Everson G Lasseter KC Anderson KE	2000	Br J Clin Pharmacol2000，49，1：	1
12	Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet显示文摘	Rudy DW Lasseter KC	2000	Ann Intern Med2000，133，1：	1
13	Pharmacokinetics and safety assessments of galantamine and risperidone after the two drugs are administered alone and together显示文摘	Lasseter KC Jassens L	2002	J Clin Pharmacol2002，42，：	1
14	The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function 显示文摘	Everson G Lassete KC Anderon	2000	Br J clinpharmacol2000，49，：	1
15	Pharmacokinetic and safety asse -ssments of galantamine and risperidone after the two drug are administered alone and together 显示文摘	Huang F Lasseter KC Janssens L	2002	J Clin Pharmacol2002，42，12：	1
16	Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension显示文摘	Mistry GC Maes AL Lasseter KC	2008	J Clin Pharmacol2008，48，5：	1
17	The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function显示文摘	Lasseter KC Anderson KE	2000	Br J Clin Pharmacol2000，49，1：	1
18	The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function显示文摘	Everson G Lasseter KC Anderson KE	2000	Br J Clin Pharmacol2000，49，1：	1
19	The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function 显示文摘	Eversong Lasseter KC Anderson KE	1997	Eur Neuropsychopharmacol1997，7，2：	1
20	Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together显示文摘	Huang F Lasseter KC Janssens L	2002	J Clin Pharmacol2002，42，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示